This Nanotechnology Customer Partnership initiative is designed and developed to be a forum to share ideas, experiences, and insights between individual users and the USPTO. The USPTO does not intend to use these customer partnership groups to arrive at a group consensus. Individual opinions are sought from varying participants, and the meetings are intended to be informal in nature. These customer partnership groups are formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and are not established as FACA compliant committees.
Introduction and Overview - Bruce Kisliuk, Group Director, TC1600
Accelerated Examination Program - Wendy Garber, Acting Director, TC2100
Overview of International Nanotech Classification Issues - B. Bill Baumeister, USPTO Classification Team
Nanotechnology Speakers: Angela Belcher, MIT: "Self-Assembled Nanostructures from Engineered Viruses and Peptides"; Samuel Stupp, Northwestern: "Crafting Bioactivity with Nanotechnology". Host: Stephen Maebius, law firm of Foley & Lardner
Open Floor Discussion
DATE AND LOCATION : This meeting is scheduled for Thursday, May 3, 2007, from 1:00 pm to 5:00 pm, in the South Auditorium, Madison Building, Concourse Level, located at 600 Dulany Street, in Alexandria, Virginia.
Requests for Attendance at the Partnership Meeting
Due to space limitations, please RSVP by e-mail to email@example.com or by telephone to Jill Warden at (571) 272-1267 to confirm your attendance. If it becomes necessary to restrict the number of attendees, we will do so on a first come-first served basis.